|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01244 3D MEDICINES
Nominal 
3.290 +0.010 (+0.305%) | 2025/12 - Final RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | (159,257) | (210,578) | (144,413) | (278,779) | (377,079) |
| Net Cash from / (used in) Investing Activities | (21,466) | 17,952 | (187,579) | (242,106) | (98,871) |
| Net Cash from / (used in) Financing Activities | (91,939) | (33,919) | 304,511 | 408,413 | 840,082 |
| Increase / (Decrease) in Cash & Cash Equivalents | (272,662) | (226,545) | (27,481) | (112,472) | 364,132 |
| Cash & Cash Equivalents at beginning of period | 444,318 | 666,472 | 696,740 | 774,306 | 414,261 |
| Effect of Foreign Exchange Rate Changes | (1,416) | 4,391 | (2,787) | 34,906 | (4,087) |
| Others | 0 | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 170,240 | 444,318 | 666,472 | 696,740 | 774,306 |
| Remarks: | Real time quote last updated: 03/06/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -177,531 |
| %Change | -2.810% |
| EPS / (LPS) | RMB -0.720 |
| NBV Per Share (¥) | RMB 2.311 |